Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).| Product Name | TXNIP [JM60-35] |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | EST01027 antibody HHCPA78 antibody THIF antibody Thioredoxin binding protein 2 antibody Thioredoxin interacting protein antibody Thioredoxin-binding protein 2 antibody Thioredoxin-interacting protein antibody TXNIP antibody TXNIP_HUMAN antibody Upregulated by 1,25 dihydroxyvitamin D 3 antibody VDUP1 antibody Vitamin D3 up-regulated protein 1 antibody |
| Product description | May act as an oxidative stress mediator by inhibiting thioredoxin activity or by limiting its bioavailability. Interacts with COPS5 and restores COPS5-induced suppression of CDKN1B stability, blocking the COPS5-mediated translocation of CDKN1B from the nucleus to the cytoplasm. Functions as a transcriptional repressor, possibly by acting as a bridge molecule between transcription factors and corepressor complexes, and over-expression will induce G0/G1 cell cycle arrest. Required for the maturation of natural killer cells. |
| Immunogen | Recombinant protein |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG |
| Host Species | Recombinant rabbit |
| Tested Applications | WBICC/IFIHCFC |
| WB:1:500~1:2000 ICC/IF:1:200~1:500 IHC:1:50~1:200 FC:1:200~1:500 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Alternative Names | EST01027 antibody
HHCPA78 antibody
THIF antibody
Thioredoxin binding protein 2 antibody
Thioredoxin interacting protein antibody
Thioredoxin-binding protein 2 antibody
Thioredoxin-interacting protein antibody
TXNIP antibody
TXNIP_HUMAN antibody
Upregulated by 1 25 dihydroxyvitamin D 3 antibody VDUP1 antibody Vitamin D3 up-regulated protein 1 antibody |
|---|---|
| Molecular Weight(MW) | 44 kDa |
| Cellular Localization | Cytoplasm. |
Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with TXNIP antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).| Positive Control | PC-12 cell lysate, human skeletal muscle tissue lysate, NIH-3T3, Hela, SH-SY5Y, human kidney tissue, human stomach cancer tissue, mouse kidney tissue, mouse stomach tissue. |
|---|---|
| Application Notes | WB:1:500~1:2000 ICC/IF:1:200~1:500 IHC:1:50~1:200 FC:1:200~1:500 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
